saridon
Commercial- Indications
- Pain, Headache
Company intelligence / Profile preview
Piramal Pharma Limited
Mumbai, Maharashtra, Indiapiramalpharma.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Piramal Pharma reported 14% YoY revenue growth for 9M FY25, primarily driven by high-teen growth in the CDMO business. EBITDA grew by 20% YoY for 9M FY25, supported by operating leverage, cost optimization initiatives and superior revenue mix[5].
- Therapeutic areas
- ImmunologyGastroenterologyOphthalmologyInfectious Diseases
- Modalities
- Inhalation anestheticsinjectable pain therapiesintrathecal treatmentsspecialty pharmaceuticals
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
AbbVie (joint venture)CSC partnership for distribution[3][4]
Beyond the preview
Go deeper on Piramal Pharma Limited.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Piramal Pharma Limited.